• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国的睾酮检测:价格透明度有限且差异显著。

Testosterone testing in the United States: limited price transparency and significant variability.

作者信息

DeMasi Matthew, Sellke Nicholas, Mortach Sherry, Rhodes Stephen, Brant Aaron, Tay Kimberly, Sun Helen H, Ghayda Ramy Abou, Loeb Aram, Thirumavalavan Nannan

机构信息

Case Western Reserve University School of Medicine, Cleveland, OH, USA.

Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

出版信息

Int J Impot Res. 2025 Aug 13. doi: 10.1038/s41443-025-01152-0.

DOI:10.1038/s41443-025-01152-0
PMID:40804464
Abstract

In response to the 2021 Hospital Price Transparency Regulation by The Centers for Medicare & Medicaid Services (CMS), we evaluated hospital-reported price transparency and variability for testosterone (T) testing across the United States (US). Using the Turquoise database, hospitals disclosing free or total T test prices were identified. Hospital characteristics were compared between price reporters and non-reporters. Multivariable regression identified reporting predictors and assessed price variability by test and payer type. Of 6700 hospitals, 51.7% reported at least one T test price. Reporting was more common among larger hospitals (median 100 vs. 75 beds, p < 0.001), non-profits (62.7 vs. 44.3%, p < 0.001), and those with higher compliance scores (4.5 vs. 3, p < 0.001). Regional variation was significant (p < 0.001), but no urban-rural differences were observed (p = 0.71). Median prices were $84.90 (Interquartile range $44.0, $138.0) for total T and $92.27 ($49.17, $144.35) for free T, varying by payer: $79.43 ($40.82, $131.32) for commercial insurance and $98.00 ($54.65, $148.84) for self-pay. On multivariable analysis, hospitals in competitive markets and with more beds tended to have lower prices, while hospital ownership did not significantly affect pricing. Despite the legislation, nearly half of hospitals fail to report prices, driving significant price variation and limiting informed consumer choices.

摘要

为响应美国医疗保险和医疗补助服务中心(CMS)2021年的医院价格透明度规定,我们评估了美国各地医院报告的睾酮(T)检测价格透明度和变异性。使用绿松石数据库,识别出披露游离或总T检测价格的医院。比较了价格报告医院和非报告医院的特征。多变量回归确定了报告预测因素,并按检测类型和付款人类型评估了价格变异性。在6700家医院中,51.7%报告了至少一种T检测价格。在大型医院(中位数为100张床位,而不是75张床位,p<0.001)、非营利性医院(62.7%对44.3%,p<0.001)以及合规得分较高的医院(4.5对3,p<0.001)中,报告更为常见。地区差异显著(p<0.001),但未观察到城乡差异(p=0.71)。总T的中位数价格为84.90美元(四分位间距为44.0美元,138.0美元),游离T的中位数价格为92.27美元(49.17美元,144.35美元),因付款人而异:商业保险为79.43美元(40.82美元,131.32美元),自费为98.00美元(54.65美元,148.84美元)。多变量分析显示,竞争市场中的医院和床位较多的医院价格往往较低,而医院所有权对定价没有显著影响。尽管有这项立法,但近一半的医院未能报告价格,导致价格差异巨大,并限制了消费者的明智选择。

相似文献

1
Testosterone testing in the United States: limited price transparency and significant variability.美国的睾酮检测:价格透明度有限且差异显著。
Int J Impot Res. 2025 Aug 13. doi: 10.1038/s41443-025-01152-0.
2
Playing by the Rules? Tracking U.S. Hospitals' Responses to Federal Price Transparency Regulation.遵守规则?追踪美国医院对联邦价格透明度法规的回应。
J Healthc Manag. 2024;69(1):45-58. doi: 10.1097/JHM-D-23-00014.
3
Uncovering the interhospital price variations for vasectomies in the United States.揭示美国输精管切除术的医院间价格差异。
Int J Impot Res. 2024 Feb 22. doi: 10.1038/s41443-024-00833-6.
4
Potential Factors Associated With Commercial-to-Medicare Relative Prices at the Substate Level.州以下层面商业保险与医疗保险相对价格的潜在相关因素。
JAMA Health Forum. 2025 Jul 3;6(7):e251640. doi: 10.1001/jamahealthforum.2025.1640.
5
Gender-Affirming Surgery Price Transparency and Online Information Availability in US Hospitals.美国医院性别肯定手术的价格透明度和在线信息可及性
Aesthetic Plast Surg. 2025 Jun 24. doi: 10.1007/s00266-025-05017-1.
6
Within-Hospital Price Gaps Across National Insurers.不同国家医保机构之间的院内价格差异。
JAMA Netw Open. 2024 Dec 2;7(12):e2451941. doi: 10.1001/jamanetworkopen.2024.51941.
7
State Health Care Regulations and Political Affiliation Associated With Total Hip Arthroplasty Prices Across the United States.美国各州医疗保健法规及政治派别与全髋关节置换术价格的关联
J Arthroplasty. 2025 Aug;40(8S1):S30-S35. doi: 10.1016/j.arth.2025.04.007. Epub 2025 Apr 11.
8
Trends in hospital price transparency after implementation of the CMS Final Rule.CMS 最终规则实施后医院价格透明度的趋势。
Health Serv Res. 2024 Aug;59(4):e14329. doi: 10.1111/1475-6773.14329. Epub 2024 May 28.
9
Neuraminidase inhibitors for preventing and treating influenza in adults and children.用于预防和治疗成人及儿童流感的神经氨酸酶抑制剂。
Cochrane Database Syst Rev. 2014 Apr 10;2014(4):CD008965. doi: 10.1002/14651858.CD008965.pub4.
10
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.阿德福韦酯与聚乙二醇化干扰素α-2a治疗慢性乙型肝炎:系统评价与经济学评估
Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280.

本文引用的文献

1
European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2025 Update on Male Hypogonadism, Erectile Dysfunction, Premature Ejaculation, and Peyronie's Disease.欧洲泌尿外科学会男性性与生殖健康指南:2025年男性性腺功能减退、勃起功能障碍、早泄和佩罗尼氏病更新版
Eur Urol. 2025 Jul;88(1):76-102. doi: 10.1016/j.eururo.2025.04.010. Epub 2025 May 8.
2
Trends in hospital price transparency after implementation of the CMS Final Rule.CMS 最终规则实施后医院价格透明度的趋势。
Health Serv Res. 2024 Aug;59(4):e14329. doi: 10.1111/1475-6773.14329. Epub 2024 May 28.
3
Tennessee hospital noncompliance with price transparency legislation for 8 common laboratory tests.
田纳西州的医院未遵守 8 项常见实验室检测的价格透明度法规。
Am J Clin Pathol. 2024 Nov 4;162(5):450-454. doi: 10.1093/ajcp/aqae057.
4
Large Variations in the Prices of Urologic Procedures at Academic Medical Centers 1 Year After Implementation of the Price Transparency Final Rule.学术医疗中心在实施价格透明度最终规定 1 年后泌尿科手术价格的大幅波动。
JAMA Netw Open. 2023 Jan 3;6(1):e2249581. doi: 10.1001/jamanetworkopen.2022.49581.
5
Not Clearing the Air: Hospital Price Transparency for a Laparoscopic Cholecystectomy.未改善空气质量:腹腔镜胆囊切除术的医院价格透明度。
J Surg Res. 2022 Dec;280:501-509. doi: 10.1016/j.jss.2022.07.037. Epub 2022 Sep 5.
6
Hospital Price Transparency in the United States: An Examination of Chargemaster, Cash, and Negotiated, Price Variation for 14 Common Procedures.美国医院价格透明度:对 14 种常见手术的 chargemaster、现金和协商价格变化的考察。
Med Care. 2022 Oct 1;60(10):768-774. doi: 10.1097/MLR.0000000000001761. Epub 2022 Aug 10.
7
Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.不到三分之一的医院提供符合要求的全膝关节置换术价格透明度信息。
Clin Orthop Relat Res. 2022 Dec 1;480(12):2316-2326. doi: 10.1097/CORR.0000000000002288. Epub 2022 Jun 24.
8
Charges for Shoppable Musculoskeletal Imaging Examinations: CMS Transparency Compliance and Variability Among 250 U.S. Hospitals.可购物的肌肉骨骼成像检查收费:CMS 透明度合规性以及 250 家美国医院之间的差异。
AJR Am J Roentgenol. 2022 Jun;218(6):1102-1103. doi: 10.2214/AJR.21.27008. Epub 2022 Jan 19.
9
Factors Associated with Compliance to the Hospital Price Transparency Final Rule: a National Landscape Study.与遵守医院价格透明度最终规则相关的因素:一项全国性研究
J Gen Intern Med. 2022 Nov;37(14):3577-3584. doi: 10.1007/s11606-021-07237-y. Epub 2021 Dec 13.
10
Availability of prices for shoppable services on hospital internet sites.医院网站上可购买服务的价格提供情况。
Am J Manag Care. 2021 Dec 1;27(12):e426-e428. doi: 10.37765/ajmc.2021.88690.